THE former bass player of superstar Scottish rock band, Simple Minds, is set to play at Skipton Sound Bar in November. Derek ...
Derek Forbes has spoken about his musical influences and more, in an exclusive interview with the Craven Herald.
Following the huge ongoing success of their Global Tour, which kicked off in 2024 and is their largest since 1985, Simple ...
Another tear-jerker from Brilliant Minds! When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. First things first! The main patient of the week ...
Then you mix in the fact that Miami was so overdue to get one over on the Bills after losing 12 of the 14 games between the ...
Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the ...
Brilliant Minds has improved each episode by adding more impactful cases and emotional character arcs. Steve Howey guest-starred on Brilliant Minds Season 1 Episode 3 as Dr. Wolf’s friend and ...
That's why Marantz has braved new ground, by looking to embrace a new era and potential new customer base, with its first-ever wireless speaker series: the Horizon and Grand Horizon. And back in ...
This week, Elton John publicly renounced the Rocket Man — no, not the 1972 song, but Elon Musk, whom he called an “a**hole” in an awards ceremony. Sir Elton, 77, is only the latest among ...
Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.
Bright Minds' drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating ...
VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non ...